Using recombinase‐mediated cassette exchange to engineer MIN6 insulin‐secreting cells based on a newly identified safe harbor locus
Autor: | Aya Tanaka, Midori Yamana, Hisamitsu Ishihara, Suguru Yamaguchi, Akiko Nagasawa, Genta Kohno, Asami Furukawa, Minami Kosuda |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
Basic Science and Research
endocrine system Endocrinology Diabetes and Metabolism Transgene medicine.medical_treatment Population Locus (genetics) Diseases of the endocrine glands. Clinical endocrinology Cell Line Recombinases Mice Insulin-Secreting Cells Glucokinase Diabetes Mellitus Internal Medicine medicine Animals Humans education Gene education.field_of_study business.industry Recombinase-mediated cassette exchange Insulin Insulin secretion Articles General Medicine RC648-665 Tetracycline‐regulated expression Rats Cell biology Recombination‐mediated cassette exchange Genetic Loci Cell culture Original Article business Rho Guanine Nucleotide Exchange Factors Transcription Factors |
Zdroj: | Journal of Diabetes Investigation, Vol 12, Iss 12, Pp 2129-2140 (2021) Journal of Diabetes Investigation |
ISSN: | 2040-1116 2040-1124 |
Popis: | Aims/Introduction Recent studies have identified genomic and transcript level changes along with alterations in insulin secretion in patients with diabetes and in rodent models of diabetes. It is important to establish an efficient system for testing functional consequences of these changes. We aimed to generate such a system using insulin‐secreting MIN6 cells. Materials and Methods MIN6 cells were first engineered to have a tetracycline‐regulated expression system. Then, we used the recombination‐mediated cassette exchange strategy to explore the silencing‐resistant site in the genome and generated a master cell line based on this site. Results We identified a site 10.5 kbps upstream from the Zxdb gene as a locus that allows homogenous transgene expression from a tetracycline responsible promoter. Placing the Flip/Frt‐based platform on this locus using CRISPR/Cas9 technology generated modified MIN6 cells applicable to achieving cassette exchange on the genome. Using this cell line, we generated MIN6 subclones with over‐ or underexpression of glucokinase. By analyzing a mixed population of these cells, we obtained an initial estimate of effects on insulin secretion within 6 weeks. Furthermore, we generated six MIN6 cell sublines simultaneously harboring genes of inducible overexpression with unknown functions in insulin secretion, and found that Cited4 and Arhgef3 overexpressions increased and decreased insulin secretion, respectively. Conclusions We engineered MIN6 cells, which can serve as a powerful tool for testing genetic alterations associated with diabetes, and studied the molecular mechanisms of insulin secretion. A platform for recombinase‐mediated cassette exchange is placed by a genetic editing method. This allows easy and efficient generation of insulin‐secreting cells with modified expressions of genes of interest. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |